COVID-19 In Vitro Diagnostic Rapid Tests
COVID-19 Ag Test
COVID-19 Ag Test is used for qualitative detection of the COVID-19 antigen in human nasopharyngeal swab specimen.
Sensitivity: 98.1% Specificity: 99.6% Total Agreement: 99.2%
- Specimen: Nasopharyngeal Swab
- Detection Time: 10-15 Minutes
- Storage: store at 2-30 °C
- No need for extra equipment
- High Accuracy
- Shelf life: 24 months
Influenza A+B & COVID-19 Ag Combo Test
The Influenza A+b & COVID-19 Ag Combo Test is an in vitro immunochromatographic assay for the qualitative and differential detection of nucleocapsid protein antigen from influenza A (including the subtype H1N1), influenza B and/or SARD-Co-V-2 in nasopharyngeal (NP) swab specimens. It is intended to aid in the rapid diagnosis of influenza A, influenza B and/or SARS-Co-V-2 infections. This test provides only a preliminary test result.
- Influenza A: Sensitivity- 98.7%, Specificity- 98.3%, Total Agreement- 98.5%
- Influenza B: Sensitivity- 98.8%, Specificity- 98.2%, Total Agreement- 98.5%
- COVID-19 Ag: Sensitivity- 98.1%, Specificity- 99.6%, Total Agreement- 99.2%
- Storage: store at 2-30°C / Shelf Life: 24 months
COVID-19 IgM/IgG Ab Test
COVID-19 IgM/IgG Ab Test, engineered with a principle that involves antibody-antigen reaction, nano-colloidal gold and immunochromatography technology, is a fast and effective method for qualitative detection of the IgM and IgG antibodies of SARS-CoV-2 in human serum, plasma or whole blood.
It is capable of measuring the body’s immune response and can also suggest information on the stage of infection – indicating both past exposure and infection by novel coronavirus.
- IgM Sensitivity: 90%, Specificity: 100%, Accuracy: 96.7%
- IgG Sensitivity: 91%, Specificity: 99%, Accuracy: 96.3%
- IgM/IgG Total Sensitivity: 95%, Specificity: 99%, Accuracy: 97.7%
- Sample Volume: 10µL fingertip blood
- Detection Time: 10-15 minuets
- No need for extra equipment
- CE Certified
COVID-19 Neutralizing Ab Test
COVID-19 Neutralizing Ab Test is used for qualitative detection of the Neutralizing antibodies in petients who have recovered from Novel Coronavirus Pneumonia or those who have been vaccinated.
- Sensitivity: 99.2%
- Specificity: 99.3%
- Total Agreement: 99.3%
858-336-0006
AgAb@Jtests.com
9909 Huennekens St,
San Diego CA 92121
